Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia
Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy (how well the drug works), safety, and
side effects of paliperidone palmitate injection compared to placebo in the treatment of the
symptoms of schizophrenia in adults. The placebo used in this study was a nutritional
substance known as 20% Intralipid emulsion given to patients requiring intravenous feedings.
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.